CN112384240B - 糖缀合物疫苗 - Google Patents

糖缀合物疫苗 Download PDF

Info

Publication number
CN112384240B
CN112384240B CN201980029219.5A CN201980029219A CN112384240B CN 112384240 B CN112384240 B CN 112384240B CN 201980029219 A CN201980029219 A CN 201980029219A CN 112384240 B CN112384240 B CN 112384240B
Authority
CN
China
Prior art keywords
streptococcus pneumoniae
protein
vaccine
capsular
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980029219.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN112384240A (zh
Inventor
B·雷恩
J·布朗
J·卡库一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
London School of Hygiene & Tropical Medicine
UCL Business Ltd
Original Assignee
London School of Hygiene & Tropical Medicine
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by London School of Hygiene & Tropical Medicine, UCL Business Ltd filed Critical London School of Hygiene & Tropical Medicine
Priority to CN202411403758.XA priority Critical patent/CN119454925A/zh
Publication of CN112384240A publication Critical patent/CN112384240A/zh
Application granted granted Critical
Publication of CN112384240B publication Critical patent/CN112384240B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201980029219.5A 2018-05-03 2019-05-02 糖缀合物疫苗 Active CN112384240B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202411403758.XA CN119454925A (zh) 2018-05-03 2019-05-02 糖缀合物疫苗

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1807303.1 2018-05-03
GBGB1807303.1A GB201807303D0 (en) 2018-05-03 2018-05-03 Glyconjugate vaccines
PCT/EP2019/061266 WO2019211386A1 (en) 2018-05-03 2019-05-02 Glyconjugate vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202411403758.XA Division CN119454925A (zh) 2018-05-03 2019-05-02 糖缀合物疫苗

Publications (2)

Publication Number Publication Date
CN112384240A CN112384240A (zh) 2021-02-19
CN112384240B true CN112384240B (zh) 2024-10-29

Family

ID=62598278

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201980029219.5A Active CN112384240B (zh) 2018-05-03 2019-05-02 糖缀合物疫苗
CN202411403758.XA Pending CN119454925A (zh) 2018-05-03 2019-05-02 糖缀合物疫苗

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202411403758.XA Pending CN119454925A (zh) 2018-05-03 2019-05-02 糖缀合物疫苗

Country Status (6)

Country Link
US (2) US12048743B2 (cg-RX-API-DMAC7.html)
EP (1) EP3787675A1 (cg-RX-API-DMAC7.html)
JP (2) JP7511188B2 (cg-RX-API-DMAC7.html)
CN (2) CN112384240B (cg-RX-API-DMAC7.html)
GB (1) GB201807303D0 (cg-RX-API-DMAC7.html)
WO (1) WO2019211386A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4748391A1 (en) * 2024-11-20 2026-05-27 MinervaX ApS N-terminal region of a group b streptococcus surface protein as a carrier for the capsular polysaccharide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216286A1 (en) * 2016-06-17 2017-12-21 Glaxosmithkline Biologicals S.A. Immunogenic composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
WO1990014837A1 (en) 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
SE0202110D0 (sv) 2002-07-05 2002-07-05 Isconova Ab Iscom preparation and use thereof
SE0301998D0 (sv) 2003-07-07 2003-07-07 Isconova Ab Quil A fraction with low toxicity and use thereof
GB0421083D0 (en) * 2004-09-22 2004-10-27 Glaxosmithkline Biolog Sa Purification process
SI2257307T1 (sl) 2008-02-20 2018-09-28 Glaxosmithkline Biologicals S.A. Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
US20120135037A1 (en) 2009-06-01 2012-05-31 Mizel Steven B Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
CN103533954B (zh) 2011-03-02 2015-09-09 诺华股份有限公司 含较低剂量的抗原和/或佐剂的联合疫苗
US9040057B2 (en) 2011-09-25 2015-05-26 Chang Gung Medical Foundation, Linkou Branch Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases
WO2013131983A1 (en) * 2012-03-07 2013-09-12 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
GB201301085D0 (en) 2013-01-22 2013-03-06 London School Hygiene & Tropical Medicine Glycoconjugate Vaccine
EP4272750A3 (en) * 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216286A1 (en) * 2016-06-17 2017-12-21 Glaxosmithkline Biologicals S.A. Immunogenic composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection;Jeremy S. Brown等;Infect Immun;20011231;第69卷(第11期);摘要,第6704页右栏第2段 *

Also Published As

Publication number Publication date
GB201807303D0 (en) 2018-06-20
CN112384240A (zh) 2021-02-19
JP2021526547A (ja) 2021-10-07
CN119454925A (zh) 2025-02-18
EP3787675A1 (en) 2021-03-10
WO2019211386A1 (en) 2019-11-07
US12472249B2 (en) 2025-11-18
US20230241208A1 (en) 2023-08-03
JP7511188B2 (ja) 2024-07-05
US12048743B2 (en) 2024-07-30
JP2024041903A (ja) 2024-03-27
JP7833736B2 (ja) 2026-03-23
US20240382585A1 (en) 2024-11-21

Similar Documents

Publication Publication Date Title
US11572391B2 (en) Antibodies for prevention, treatment and diagnosis of P. gingivalis infection
US7960535B2 (en) Recombinant lipidated PsaA protein, methods of preparation and use
CN101855238B (zh) 融合蛋白疫苗
US11484584B2 (en) Immunogenic complex for eliciting protective immunity against group B Streptococcus
US20180256698A1 (en) Proline-rich peptides protective against s. pneumoniae
JP2021528059A (ja) グリコシル化されたComPピリンバリアント、製造方法及びその使用
CN112153980A (zh) 包含葡萄球菌抗原的免疫原性组合物
US7255863B2 (en) Group A streptococcal vaccines
CN113164580A (zh) 肺炎球菌融合蛋白疫苗
WO2009143413A1 (en) Synergistic immunogenic fusion protein-polysaccharide conjugate
JP2017160238A (ja) ストレプトコッカス・ニューモニエ(Streptococcus pneumoniae)に対する融合抗原ワクチンおよび組成物
US12472249B2 (en) Glyconjugate vaccines
CN102488898B (zh) 龋齿疫苗及制备方法
WO2018009906A1 (en) Whole cell-protein conjugates and methods of making the same
JP2018522978A (ja) 免疫原性組成物
CA3079111A1 (en) Comprehensive vaccine design for commensal disease progression
US8691243B2 (en) Protein-based Streptococcus pneumoniae vaccine
HK40079037A (zh) 脑膜炎奈瑟氏球菌疫苗及其应用
WO2024081906A1 (en) A maps vaccine targeting group b streptococcus (gbs)
HK1250933A1 (en) Immunogenic fusion protein

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant